GROUP ONE TRADING LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is and the CUSIP is 462260950. A total of 4 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$2,137,330
-40.5%
266,500
+10.0%
0.01%
-42.9%
Q1 2024$3,590,886
+45.1%
242,300
-20.4%
0.01%
+100.0%
Q4 2023$2,475,585
+14.5%
304,500
-35.9%
0.01%0.0%
Q3 2023$2,162,160
+142.4%
475,200
+275.1%
0.01%
+133.3%
Q2 2023$891,968
+205.4%
126,700
+165.1%
0.00%
+200.0%
Q1 2023$292,058
-78.9%
47,800
-77.9%
0.00%
-66.7%
Q4 2022$1,384,074
+1674.5%
216,600
+2574.1%
0.00%
Q3 2022$78,000
-30.4%
8,100
-19.8%
0.00%
Q2 2022$112,000
-76.0%
10,100
-63.9%
0.00%
Q1 2022$466,000
-71.7%
28,000
-67.5%
0.00%
-100.0%
Q4 2021$1,644,000
-17.4%
86,100
+6.7%
0.00%
-50.0%
Q3 2021$1,990,000
-38.4%
80,700
-35.0%
0.00%
-50.0%
Q2 2021$3,232,000
+320.3%
124,200
+411.1%
0.00%
+300.0%
Q1 2021$769,000
-70.6%
24,300
-56.9%
0.00%
-80.0%
Q4 2020$2,617,000
+32.3%
56,400
-6.2%
0.01%
-16.7%
Q3 2020$1,978,000
-41.8%
60,100
-51.5%
0.01%
-62.5%
Q2 2020$3,398,000
+18.0%
123,800
+28.7%
0.02%
-30.4%
Q1 2020$2,880,000
+192.4%
96,200
+170.2%
0.02%
+228.6%
Q4 2019$985,000
+397.5%
35,600
+226.6%
0.01%
+250.0%
Q3 2019$198,000
-20.2%
10,900
+7.9%
0.00%0.0%
Q2 2019$248,000
+78.4%
10,100
-35.7%
0.00%
+100.0%
Q4 2018$139,000
-50.2%
15,700
-28.0%
0.00%
-50.0%
Q2 2018$279,000
+15.3%
21,800
+52.4%
0.00%0.0%
Q1 2018$242,000
+554.1%
14,300
+186.0%
0.00%
Q2 2017$37,0005,0000.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING LLC 47,800$292,0580.00%
SIMPLEX TRADING, LLC 44,300$2700.00%
JANE STREET GROUP, LLC 41,500$253,5650.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders